Segui
Robert K Mahar
Robert K Mahar
Altri nomiRobert Mahar
Senior Research Fellow, University of Melbourne
Email verificata su unimelb.edu.au
Titolo
Citata da
Citata da
Anno
Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation
CM Algie, RK Mahar, HB Tan, G Wilson, PD Mahar, J Wasiak
Cochrane Database of Systematic Reviews, 2015
1502015
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
SYC Tong, J Mora, AC Bowen, MP Cheng, N Daneman, AL Goodman, ...
Clinical Infectious Diseases 75 (11), 2027-2034, 2022
622022
Interventions for reducing wrong‐site surgery and invasive clinical procedures
CM Algie, RK Mahar, J Wasiak, L Batty, RL Gruen, PD Mahar
Cochrane Database of Systematic Reviews, 2015
302015
A scoping review of studies using observational data to optimise dynamic treatment regimens
RK Mahar, MB McGuinness, B Chakraborty, JB Carlin, MJ IJzerman, ...
BMC medical research methodology 21, 1-13, 2021
262021
Peer Reviewed: The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia
M Ishida, ESG Hulse, RK Mahar, J Gunn, R Atun, B McPake, N Tenneti, ...
Preventing Chronic Disease 17, 2020
232020
Anticoagulation strategies in non–critically ill patients with Covid-19
ZK McQuilten, B Venkatesh, V Jha, J Roberts, SC Morpeth, JA Totterdell, ...
NEJM Evidence 2 (2), EVIDoa2200293, 2023
132023
Lack of transparency in software used to analyze multiple breath washout data
RK Mahar, D Vukcevic, L King, JB Carlin, S Ranganathan
Pediatric Pulmonology 51 (11), 1108-1110, 2016
122016
Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review
CJ Selman, KJ Lee, CL Whitehead, BJ Manley, RK Mahar
Trials 24 (1), 1-7, 2023
102023
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
D de Kretser, J Mora, M Bloomfield, A Campbell, MP Cheng, S Guy, ...
Clinical Infectious Diseases, ciad666, 2023
92023
A randomized trial of nafamostat for Covid-19
SC Morpeth, B Venkatesh, JA Totterdell, GM McPhee, RK Mahar, M Jones, ...
NEJM Evidence 2 (11), EVIDoa2300132, 2023
62023
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials
MP Hernández-Mitre, SC Morpeth, B Venkatesh, TE Hills, J Davis, ...
INPLASY-International Platform of Registered Systematic Review and Meta …, 2023
5*2023
Improving clinical trials using Bayesian adaptive designs: a breast cancer example
W Hong, SA McLachlan, M Moore, RK Mahar
BMC Medical Research Methodology 22 (1), 133, 2022
52022
Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
IC Marschner, M Jones, JA Totterdell, RK Mahar, TL Snelling, SYC Tong
BMJ medicine 2 (1), 2023
42023
Bayesian modelling of lung function data from multiple‐breath washout tests
RK Mahar, JB Carlin, S Ranganathan, AL Ponsonby, P Vuillermin, ...
Statistics in medicine 37 (12), 2016-2033, 2018
42018
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents …
A Pereira-Salgado, A Anton, F Franchini, RK Mahar, EM Kwan, S Wong, ...
Expert review of pharmacoeconomics & outcomes research 23 (2), 231-239, 2023
22023
Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19
Z McQuilten, B Venkatesh, V Jha, J Roberts, S Morpeth, J Totterdell, ...
Blood 140 (Supplement 1), 326-328, 2022
22022
A general Bayesian approach to design adaptive clinical trials with time-to-event outcomes
JM McGree, AM Overstall, M Jones, RK Mahar
arXiv preprint arXiv:2303.00901, 2023
12023
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
P Gillett, RK Mahar, NR Tran, M Rosenthal, M IJzerman
Cost Effectiveness and Resource Allocation 21 (1), 87, 2023
2023
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)
N Anagnostou, S Archuleta, E Athan, L Barina, E Best, M Bloomfield, ...
OXFORD UNIV PRESS INC, 2023
2023
Outcome-adaptive randomisation in a multi-arm breast cancer trial
W Hong, SA McLachlan, M Moore, RK Mahar
2022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20